Preparation method of antibacterial peptide gene and encoding peptide and prokaryotic expression thereof Pomfret brandt
A prokaryotic expression and antimicrobial peptide technology, which is applied in the field of aquatic animal immunity, can solve the problems of strong bacterial drug resistance and crisis ecological security, and achieve the effect of easy degradation and drug resistance
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Example Embodiment
[0038] Example 1 The preparation method of the antimicrobial peptide gene of Brycephalus pomfret and the peptide encoded and prokaryotic expression thereof includes the following steps:
[0039] 1) Cloning and purification of the TroLEAP-2 fragment of the antibacterial peptide gene of Brycephalus pomfret
[0040] ①Extract RNA from the liver of Brandt pomfret, reverse transcription to obtain the cDNA library of Brandt's pomfret, and amplify with LEAP-2F1 / R1 primers to obtain the full-length sequence and specific sequence of the antimicrobial peptide gene TroLEAP-2 of the brandt pomfret. See SEQ NO.1.
[0041] The upstream primer LEAP-2F1:
[0042] 5’-AATTGATATCGCCACCATGGGTCCACTGGCCTCTC-3’
[0043] Downstream primer LEAP-2R1:
[0044] 5’-CTAAATTGATATCATAGTTTACGGGCTCTGAGG-3’
[0045] ②The product was purified by using a gel recovery kit to obtain a purified fragment of the antimicrobial peptide gene TroLEAP-2 of Brucet's trevally with the signal peptide removed.
[0046] ③ The purified Bromp...
Example Embodiment
[0063] Example 2: In vitro antibacterial activity experiment of recombinant Brandt pompano antibacterial peptide
[0064] (1) Colony counting method
[0065] ①Dilute the three pathogenic bacteria that grow to the logarithmic phase of Edwards tarda, Vibrio harveyi and Streptococcus agalactiae with LB medium to 1×10 5 CFU / mL.
[0066] ②Dilute the recombinant Brandt pompano antimicrobial peptide (rTroLEAP-2) and the prokaryotic expression empty carrier protein rTrx with PBS to 20μg / mL, 40μg / mL, 60μg / mL, 80μg / mL, 100μg / mL, 200μg / mL, 300μg / mL, and 100μL PBS as a negative control.
[0067] ③100μL of the diluted pathogen and 100μL of protein diluted to different concentrations were incubated at 28℃ for 3h.
[0068] ④ At the end of the incubation, dilute the incubation solution 100 times and take 100 μL for coating. Incubate overnight at 28°C.
[0069] ⑤Record the number of single colonies on each plate, the calculation formula:
[0070] Bacterial survival rate (%) = number of surviving bacteri...
Example Embodiment
[0078] Example 3: In vivo antibacterial activity experiment of recombinant brandt pomfret antibacterial peptide rTroLEAP-2
[0079] (1) Resuspend the purified recombinant Brandt pomfret antibacterial peptide protein TroLEAP-2 in PBS to a final concentration of 200 μg / mL, and then mix with the same amount of aluminum and compound adjuvant. PBS was also mixed with the same amount of aluminum and compound adjuvant as a control group.
[0080] (2) 100 Brandt pomfrets weighing about 10 g were randomly divided into 2 groups, and injected with 100 μl rTroLEAP-2+ aluminum and compound adjuvants and aluminum and compound adjuvants respectively, and were cultured in a circulating aquaculture system.
[0081] (3) Eight weeks after immunization, Edwards tarda and Streptococcus agalactiae were used to challenge the poison. Observe and record the cumulative mortality of the pompano in each group. The relative protection effect RPS calculation formula is as follows:
[0082] RPS=(1-% cumulative dea...
PUM
Property | Measurement | Unit |
---|---|---|
Relative molecular mass | aaaaa | aaaaa |
Molecular weight | aaaaa | aaaaa |
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap